Complete Response Letters recently issued by the FDA signal heightened scrutiny of trial design and reinforce the agency’s shifting regulatory expectations for sponsors and CROs.

Study design: only randomised controlled trials will be included in the study ... Figure 1 shows the PRISMA flow diagram of the literature selection in this study. Actual screening numbers will be ...

Combining insulin treatment with the investigational drug dapagliflozin may improve health outcomes for adolescents with type ...

BACKGROUND: Whether cannabis is a risk factor for cardiovascular events is unknown. We examined the association between smoking cannabis and cardiovascular events in a cohort of older veterans (66 to ...

Worried about looming tariffs on tech? Our experts review more than 1,500 products each year. Our mega-guide, updated monthly ...